1. Sakr M. Cervical: Lymphadenopathy. Head and Neck and Endocrine Surgery. 2016;163-190. Published 2016 Feb 9. doi:10.1007/978-3-319-27532-1_8
2. Lopez F, Rodrigo JP, Silver CE, Jr MH, Bishop JA, Strojan P, et al. Cervical lymph node metastases from remote primary tumor sites. Head Neck. 2016;38(Suppl 1):E2374–85.
3. Gaddey HL, Riegel AM, Bergquist E, Medicine F, Program R, Air O, et al. Unexplained Lymphadenopathy: Evaluation and Differential Diagnosis. Am Fam Physician. 2016;94(11):896–903.
4. Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A. Peripheral lymphadenopathy: Approach and diagnostic tools. Iran J Med Sci. 2014;39(2 SUPPL.):158–70.
5. Bazemore A, Smucker D. Lymphadenopathy and Malignancy. Am Fam Physician [Internet]. 2002;66(1):2103–10.
6. Spector ME, Gallagher KK, Light E, Ibrahim M, Chanowski EJ, Moyer JS, Prince ME, Wolf GT, Bradford CR, Cordell K, McHugh JB, Carey T, Worden FP, Eisbruch A, Chepeha DB; University of Michigan Head Neck Specialized Program of Research Excellence (SPORE) Program. Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status. Head Neck. 2012 Dec;34(12):1727-33. doi: 10.1002/hed.21997. Epub 2012 Jan 13. PMID: 22247002; PMCID: PMC3424373.
7. Darne S, Rajda T. Cervical Lymphadenopathy in Children: A Clinical Approach. Int J Contemp Med Res ISSN Online. 2016;43(4):2393915
8. Kanwar VS. Lymphadenopathy. Medscape. 2022. https://emedicine.medscape.com/article/956340-overview.
9. Ferrer RL. Evaluation of peripheral lymphadenopathy in adults. UpToDate. 2022. https://www.uptodate.com/contents/evaluation-of-peripheral-lymphadenopathy-in-adults.
10. Dulin FD, Kennard TP, Leach L. Management of Cervical Lymphadenitis in Children. Am Fam Physician. 2008;78(9):1097-1098. https://www.ncbi.nlm.nih.gov/pubmed/19007057
11. Friedmann AM. Evaluation and management of lymphadenopathy in children. Pediatr Rev. 2008 Feb;29(2):53-60. doi: 10.1542/pir.29-2-53. PMID: 18245301.